Loading provider…
Loading provider…
Obstetrics & Gynecology Physician in Idaho Falls, ID
NPI: 1275603193Primary Practice Location
MOUNTAIN VIEW HOSPITAL
2325 Coronado St, Idaho Falls, ID
Primary Employer
Genova Diagnostics Inc
gdx.net
HQ Phone
Get M.D. Jeffrey's Phone Numberphone_androidMobile
Get M.D. Jeffrey's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardID State Medical License
ID State Medical License
1991 - 2025
MI State Medical License
1989 - 1993

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Integrative Holistic Medicine
Integrative Medicine

Fellowship trained through Arizona Center of Integrative Medicine
Integrative Medicine
Corewell Health East Beaumont (Royal Oak)
Residency • Obstetrics and Gynecology
1988 - 1991
Banner-University Medical Center Phoenix
Internship • Transitional Year
1987 - 1988
Spencer Fox Eccles School of Medicine
medicine.utah.edu
Medical School
Until 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 46 | 85 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 19 | 22 |
Authors: Melvin Seid
Journal: Am J Obstet Gynecol
Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids.
Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy.
Authors: Amy Murtha, Sylvia Siegfried, Kim Boggess, Alan Peaceman
Journal: AJP Rep
Publication Date: 2018-05-14
Lead Sponsor: Dynogen Pharmaceuticals
Intervention / Treatment: DRUG: DDP733
Lead Sponsor: AMAG Pharmaceuticals, Inc.
Collaborators: ResearchPoint Global
Intervention / Treatment: DRUG: Vehicle, DRUG: Hydroxyprogesterone Caproate Injection (HPC), 250mg/mL